vaccinees < vaccines < vaccinia

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by vaccines

Number of relevant bibliographic references: 126.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000038 (2019)	Xavier Saelens [Belgique]	The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
000087 (2019)	Z Beau Reneer [États-Unis] ; Ted M. Ross [États-Unis]	H2 influenza viruses: designing vaccines against future H2 pandemics.
000096 (2019)	Seyed Davoud Jazayeri ; Chit Laa Poh	Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
000102 (2019)	Laura Rodriguez ; Pilar Blanco-Lobo ; Emma C. Reilly [États-Unis] ; Tatsuya Maehigashi ; Aitor Nogales ; Andrew Smith [États-Unis] ; David J. Topham [États-Unis] ; Stephen Dewhurst ; Baek Kim [Corée du Sud] ; Luis Martínez-Sobrido	Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines
000139 (2018)	Vittorio Demicheli ; Tom Jefferson ; Eliana Ferroni ; Alessandro Rivetti ; Carlo Di Pietrantonj	Vaccines for preventing influenza in healthy adults
000142 (2018)	Larisa Rudenko ; Irina Kiseleva ; Elena Krutikova ; Ekaterina Stepanova ; Irina Isakova-Sivak ; Svetlana Donina ; Andrey Rekstin ; Maria Pisareva ; Ekaterina Bazhenova ; Tatiana Kotomina ; Anastasia Katelnikova ; Arman Muzhikyan ; Valery Makarov ; Erin Grace Sparrow ; Guido Torelli	Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
000160 (2018)	Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]	Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000174 (2018)	Florian Krammer [États-Unis] ; Ron A. M. Fouchier [États-Unis, Pays-Bas] ; Maryna C. Eichelberger [États-Unis] ; Richard J. Webby [États-Unis] ; Kathryn Shaw-Saliba [États-Unis] ; Hongquan Wan [États-Unis] ; Patrick C. Wilson [États-Unis] ; Richard W. Compans [États-Unis] ; Ioanna Skountzou [États-Unis] ; Arnold S. Monto [États-Unis]	NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
000176 (2018)	Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]	Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines
000178 (2018)	D. Korenkov [Russie, Australie] ; T. H. O. Nguyen [Australie] ; I. Isakova-Sivak [Russie] ; T. Smolonogina [Russie] ; L. E. Brown [Australie] ; K. Kedzierska [Australie] ; L. Rudenko [Russie]	Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections
000213 (2018)	Sung J. Yoo [Corée du Sud] ; Taeyong Kwon [Corée du Sud] ; Young S. Lyoo [Corée du Sud]	Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure
000257 (2017)	Raffael Nachbagauer [États-Unis] ; Florian Krammer [États-Unis]	Universal influenza virus vaccines and therapeutic antibodies
000261 (2017)	Won-Suk Choi [Corée du Sud] ; Khristine Kaith S. Lloren [Corée du Sud] ; Yun Hee Baek [Corée du Sud] ; Min-Suk Song [Corée du Sud]	The significance of avian influenza virus mouse-adaptation and its application in characterizing the efficacy of new vaccines and therapeutic agents
000294 (2017)	Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie]	Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza.
000318 (2017)	Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis]	Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
000347 (2017)	Riju Ray [Belgique] ; Gaël Dos Santos ; Philip O. Buck [États-Unis] ; Carine Claeys [Belgique] ; Gonçalo Matias [Belgique] ; Bruce L. Innis [États-Unis] ; Rafik Bekkat-Berkani [Belgique]	A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
000356 (2016-12-23)	Guillermo Ruiz-Palacios [Mexique] ; Geert Leroux-Roels [Belgique] ; Jiri Beran [République tchèque] ; Jeanne-Marie Devaster [Belgique] ; Meral Esen [Allemagne] ; Odile Launay [France] ; Janet Mcelhaney [Canada] ; Gerrit Van Essen [Pays-Bas] ; Anne Benoit [Belgique] ; Carine Claeys [Belgique] ; Walthère Dewé [Belgique] ; Christelle Durand [Belgique] ; Xavier Duval [France] ; Ann Falsey [États-Unis] ; Gregory Feldman [États-Unis] ; Florence Galtier [France] ; Pierre Gervais [France] ; Shinn-Jang Hwang [Taïwan] ; Shelly Mcneil [Canada] ; Jan Hendrik Richardus [Pays-Bas] ; Andrew Trofa [États-Unis] ; Lidia Oostvogels [Belgique]	Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
000406 (2016)	Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. Weiss	Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.
000410 (2016)	Aitor Nogales ; Luis Martínez-Sobrido	Reverse Genetics Approaches for the Development of Influenza Vaccines
000445 (2016)	I. Barberis [Italie] ; P. Myles [Royaume-Uni] ; S. K. Ault [États-Unis] ; N. L. Bragazzi [Italie] ; M. Martini [Italie]	History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines
000447 (2016)	Saranya Sridhar [Royaume-Uni]	Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "vaccines" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "vaccines" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    vaccines
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021